|
| Exchange Disseminated Time | Fortis Healthcare Ltd has informed BSE regarding a Press Release dated March 14, 2011 titled "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres"
Press Release:
"Fortis Healthcare (India) Ltd, India's fastest growing hospital network and TotipotentRX Cell Therapy Pvt. Ltd, a leading provider of cutting-edge technologies in the stem cell and regenerative medicine market, announced a collaboration to set up centres of excellence offering cellular therapies and stem cell clinical trials, across select Fortis hospitals. These centres will undertake stem cell clinical research procedures relating to diabetes, cancer, cardiovascular disease, and neurological ischemia. TotipotentRX will also set up state-of-the-art cGMP laboratories in select hospitals, for processing stem cells before transplantation to patients.
Fortis Healthcare and TotipotentRX will leverage Fortis' hospital network and respective areas of clinical expertise to investigate new regenerative therapies, using promising adult stem cell sources like cord blood, bone marrow, and adipose tissue. As part of the alliance, a Stem Cell Medical Board will be created to oversee the medical research programme, ensure execution and monitor the progress following International and Indian ethical guidelines. The board will also impart training and create awareness around the benefits of stem cell therapy across India.
Speaking about the partnership, Shivinder Mohan Singh, Managing Director, Fortis Healthcare (India) Limited, said, "This tie-up allows Fortis to partner with the finest in the field of stem cell therapy and lead the way in this specialized new treatment modality, acknowledged to be at the cutting edge of modern medicine. This is in continuation of our effort to bring the latest in medicine to our customers, in a caring environment and at affordable prices. We will continue to pursue our vision of clinical excellence, with a focus on distinctive patient care."
In the words of Kenneth Harris, CEO, TotipotentRX (MK Alliance Inc.), "We are excited to partner with the established pan-India hospital network of Fortis Healthcare and this collaboration allows us to carry out advanced clinical research, aimed at addressing quality of life improvements for several healthcare challenges in India."
Stem Cell therapy is widely recognised to be the future of medicine due to its proven ability to repair and regenerate damaged and diseased organs and tissues. According to available literature, stem cell therapy is being used to treat diseases like peripheral arterial disease (PAD), chronic heart failure, and prostate cancer." |
|
|